What is SMRxT?
SMRxT operates at the intersection of healthcare technology and behavioral science, providing a sophisticated real-time medication adherence management system known as Nomi. The platform is engineered to capture precise data regarding patient medication habits, transforming raw inputs into actionable insights that facilitate timely clinical interventions. Unlike traditional systems that require complex patient onboarding, Nomi functions seamlessly, thereby reducing the barrier to entry for both patients and providers. Through a strategic partnership with Verizon, SMRxT ensures that its infrastructure is supported by high-reliability cellular connectivity, which is essential for maintaining the integrity of real-time health data. This technological framework not only empowers patients to manage their health more effectively but also assists healthcare providers in mitigating preventable costs and optimizing clinical productivity.
How much funding has SMRxT raised?
SMRxT has raised a total of $142K across 1 funding round:
Debt
$142K
Debt (2021): $142K with participation from PPP
Key Investors in SMRxT
PPP
Public-Private Partnership
What's next for SMRxT?
With the infusion of this late-stage capital, SMRxT is expected to scale its operations and deepen its market penetration within the healthcare ecosystem. The company's focus will likely shift toward expanding its footprint in value-based care environments, where the ability to demonstrate improved patient outcomes is directly tied to financial performance. By refining its data analytics capabilities and strengthening its existing partnerships, SMRxT is well-positioned to become a standard-bearer for digital health interventions. Future growth will likely involve integrating the Nomi platform into broader electronic health record systems, further embedding its technology into the daily workflows of clinicians and health systems nationwide.
See full SMRxT company page
